Universitaetsklinikum Leipzig Aor
Leipzig 04103
2 studies enrolling now · 4 studies all time
What they study most
Acute Myeloid Leukemia, CLL, Chronic Lymphocytic Leukemia, Cushings Disease, Hepatocellular Carcinoma (HCC), Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasm
Studies at this site
- A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors — Recruiting now
- A Study of BGB-11417 in Participants With Myeloid Malignancies — Recruiting now
- A Study of Tislelizumab Versus Sorafenib in Participants With Unresectable Hepatocellular Carcinoma (HCC) — Completed
- Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease — Completed